Financial statements K2-Med
Cash flow statement of K2-Med
Company age:
Age:
5 y. 2 m. 11 d.
Share capital:
Share capital:
35 000 PLN
Cash inflows of K2-MED
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Net cash from operating expenses | 195 251,07 | 21 658,11 | -75 411,90 |
| Net cash flow from investing activities | 0,00 | 0,00 | 0,00 |
| Net cash flow from financial activities | 0,00 | 0,00 | 12 242,85 |
| Total net cash flow | 195 251,07 | 21 658,11 | -63 169,05 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
AD
AD